Over the last few years, semaglutide has truly taken over. It's likely that you have more than one family member, friend, or colleague who's taken it and raved about the metabolic results they've seen ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

The runaway popularity of GLP-1 medications like Ozempic and Wegovy for weight loss and diabetes management led to a nationwide shortage that lasted more than a year—and created the perfect conditions ...

As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide injections are largely being phased out. While they may still be available ...

Learn more about what to expect if you’ve been prescribed this weight loss medication to help treat this chronic liver condition.

The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

While weight loss medications can deliver significant results, our bodies eventually adapt to everything. And many people end up taking GLP-1 receptor agonists like Ozempic or Wegovy for an extended ...

Drug major Sun Pharmaceutical Industries Limited has received a key regulatory clearance from the Subject Expert Committee ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

Drug major Cipla Limited has received clearance from the Subject Expert Committee (SEC) functioning under the Central Drugs ...

A new study led by a researcher at University College London (UCL) suggests that the anti-obesity drug semaglutide may reduce the risk of heart attacks and other serious cardiac events even when ...